Cost Per Results Reportable (CPRR) Automated Hematology Analyzer at Naval Medical Center Portsmouth

SOL #: 1237414Sources Sought

Overview

Buyer

DEPT OF DEFENSE

Defense Health Agency (Dha)

DEFENSE HEALTH AGENCY

FREDERICK, MD, 21702, United States

Place of Performance

Portsmouth, VA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Analysis Instruments, Medical Laboratory Use (6632)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/f0aa26241b8341b099e78fa45b4ce7c1/view

Timeline

Posted

Mar 10, 2026

Last Updated

Mar 11, 2026

Response Deadline

Mar 25, 2026, 9:00 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA), through Naval Medical Center Portsmouth, has issued a Request for Information (RFI) for a Cost Per Results Reportable (CPRR) Automated Hematology Analyzer. This RFI aims to identify potential sources and assess the commercial nature of required supplies for a new contract, as the current one expires in August 2026. Responses are due March 25, 2026.

Purpose

This RFI is for market research and planning purposes only and does not constitute a solicitation or a guarantee of a future contract. The Government will not consider unsolicited proposals or offers. Its primary goal is to gather information on industry capabilities and determine if the required supplies are commercial, in accordance with FAR Part 10.

Scope of Work

The requirement is for a CPRR Automated Hematology Analyzer system at Naval Medical Center Portsmouth, VA. Key capabilities include:

High-throughput analysis: Reliable and extensive, capable of ≥ 200 tests per hour.
Technology: Utilizes fluorescent flow cytometry to analyze RNA and DNA content and intracellular cellular structures.
Quality Control: Integrated automated QC module capable of performing, evaluating, and documenting quality control without user intervention, with traceability.
Integration: Capable of connecting with middleware and command center components for integrated total lab automation. A DRAFT Statement of Work (SOW) is available for review.

Contract & Timeline

Type: Request for Information (RFI) / Sources Sought
Set-Aside: None specified
NAICS: 334516 Analytical Laboratory Instrument Manufacturing
PSC: 6632 Analysis Instruments, Medical Laboratory Use
Response Due: March 25, 2026, by 5:00 PM EST
Published: March 11, 2026
Place of Performance: Naval Medical Center Portsmouth, 54 Lewis Minor Street, Bldg 250, Portsmouth, VA 23708.

Submission Instructions

Responses must be submitted electronically in Microsoft Word or Adobe PDF format. Submissions should include:

Cover Page (1 page): Title, Organization, Responder's technical and administrative points of contact (names, addresses, phone, email), and CAGE Code.
Capabilities Statement: Address understanding of the DRAFT SOW, experience with similar work, existing contract vehicles (e.g., GSA schedule), and whether services are provided to the general public under similar terms. Do not request a copy of the solicitation as none exists.